Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company monthly Stock Chart
Eli Lilly and Company
IndexS&P 500 P/E25.20 EPS (ttm)5.01 Insider Own12.00% Shs Outstand956.11M Perf Week-11.20%
Market Cap120.59B Forward P/E16.47 EPS next Y7.66 Insider Trans-2.83% Shs Float947.95M Perf Month-9.86%
Income4.64B PEG2.30 EPS next Q1.44 Inst Own79.50% Short Float1.33% Perf Quarter7.72%
Sales22.32B P/S5.40 EPS this Y54.10% Inst Trans0.12% Short Ratio3.58 Perf Half Y13.66%
Book/sh2.87 P/B43.95 EPS next Y12.67% ROA21.60% Target Price145.08 Perf Year-0.13%
Cash/sh2.55 P/C49.45 EPS next 5Y10.97% ROE295.80% 52W Range101.36 - 147.87 Perf YTD-4.03%
Dividend2.96 P/FCF86.58 EPS past 5Y17.40% ROI24.60% 52W High-14.70% Beta0.24
Dividend %2.35% Quick Ratio0.90 Sales past 5Y2.60% Gross Margin78.80% 52W Low24.44% ATR3.28
Employees33625 Current Ratio1.20 Sales Q/Q8.50% Oper. Margin22.50% RSI (14)23.72 Volatility3.52% 2.12%
OptionableYes Debt/Eq5.88 EPS Q/Q28.70% Profit Margin37.30% Rel Volume2.23 Prev Close129.19
ShortableYes LT Debt/Eq5.30 EarningsJan 30 BMO Payout29.40% Avg Volume3.51M Price126.13
Recom2.40 SMA20-10.74% SMA50-8.24% SMA2006.03% Volume7,829,619 Change-2.37%
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Feb-28-20 09:55AM  Pharma Stock Roundup: FDA Updates From LLY, GSK, NVS, SNY to Spin-Off API Unit Zacks
Feb-27-20 06:11PM  Biohaven drug wins U.S. FDA approval for use in relieving migraine headaches Reuters
Feb-26-20 07:27PM  FDA Advisory Committee Votes in Favor of Lilly's CYRAMZA® (ramucirumab) as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer PR Newswire
Feb-21-20 08:35PM  FDA approves Eli Lilly's Trulicity to reduce cardiovascular risks in type 2 diabetic patients Reuters
07:50PM  Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease PR Newswire
07:37PM  U.S. FDA approves Lundbeck's migraine prevention therapy Reuters
06:16PM  Mairs and Power: Top 4th-Quarter Trades
03:45PM  Lilly to Participate in Cowen Health Care Conference PR Newswire
03:10PM  Lilly To Participate in SVB Leerink Global Healthcare Conference PR Newswire
11:10AM  Pharmaceutical companies develop system to better track counterfeit drugs Reuters
Feb-20-20 05:10PM  Oscar Health unveils program for lower drug prices, including insulin Yahoo Finance
08:55AM  Lilly Completes Acquisition of Dermira PR Newswire
Feb-14-20 11:45AM  Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio Zacks
Feb-13-20 02:42PM  Leaner, More Agile Teva Sees Brighter Days Ahead
Feb-11-20 10:33AM  These Pharma Giants Took A Hit On Two More Alzheimer's Failures Investor's Business Daily
09:12AM  Lilly Reports Disappointing Data on Alzheimer's Candidate Zacks
Feb-10-20 04:19PM  US STOCKS-S&P 500, Nasdaq reach record closing highs; Chinese workers return Reuters
02:27PM  US STOCKS-Nasdaq hits new high as investors look beyond coronavirus Reuters
01:16PM  US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record Reuters
12:22PM  Eli Lilly Suffers Setback As Alzheimer's Study Fails To Meet Primary Endpoint Benzinga
12:05PM  US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record Reuters
10:32AM  US STOCKS-Wall St steady as investors weigh coronavirus risks Reuters
09:55AM  Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease Reuters
09:32AM  Eli Lilly Shares Slide After Alzheimer's Treatment Fails Clinical Trial
09:19AM  Lilly and Biogen Stocks Get Hit as Another Alzheimers Treatment Fails a Trial
08:58AM  US STOCKS-Wall Street set for subdued open as investors weigh coronavirus risks Reuters
08:01AM  Lilly's stock falls on failed Alzheimer's study MarketWatch
01:00AM  Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study PR Newswire
12:49AM  Roche and Eli Lilly drugs fail inherited Alzheimers trial Financial Times
Feb-09-20 08:00AM  Eli Lilly and Company (NYSE:LLY)'s Could Be A Buy For Its Upcoming Dividend Simply Wall St.
Feb-07-20 02:00PM  Lilly to Participate in Guggenheim Healthcare Talks Idea Forum PR Newswire
10:28AM  Teva (TEVA) to Report Q4 Earnings: What's in the Cards? Zacks
09:44AM  Incyte (INCY) to Report Q4 Earnings: What's in the Cards? Zacks
07:32AM  The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga
Feb-06-20 11:11AM  Sanofi (SNY) Q4 Earnings Top, Sales Miss, Dupixent Strong Zacks
08:44AM  The Zacks Analyst Blog Highlights: Netflix, Eli Lilly, United Parcel Service, Microsoft and Nike Zacks
Feb-05-20 02:09PM  Top Research Reports for Netflix, Eli Lilly & United Parcel Service Zacks
09:00AM  Here Are 4 Leading Pharmaceutical Stocks To Consider In Early 2020 Investor's Business Daily
06:34AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Feb-04-20 12:27PM  A Pick and Shovel Strategy to Avoid Competition and Speculation
11:50AM  Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal Zacks
10:22AM  Analysts Forecast Huge Upsides for Aimmune, Biohaven
Feb-03-20 07:04PM  3 Dividend-Paying Stocks for Investors to Buy to Fight Off Market Uncertainty Zacks
01:13PM  Are You An Income Investor? Don't Miss Out On Eli Lilly and Company (NYSE:LLY) Simply Wall St.
Jan-31-20 04:53PM  Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study Zacks
01:31PM  Edited Transcript of LLY earnings conference call or presentation 30-Jan-20 2:00pm GMT Thomson Reuters StreetEvents
10:54AM  Eli Lilly prices migraine therapy at $640 for pack of eight pills Reuters
10:43AM  Lilly's REYVOW (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription PR Newswire
10:32AM  Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative Zacks
10:15AM  Bayer Seeks FDA Approval for New Formulation of Nifurtimox Zacks
09:09AM  The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO Benzinga
06:15AM  CHMP Recommends Approval of Lilly's New Fast-Acting Mealtime Insulin to Improve Glycemic Control in Adults with Diabetes PR Newswire
Jan-30-20 04:22PM  Lilly Fends Off Sagging Drug Prices To Post Its Best Growth In 2 Years Investor's Business Daily
11:04AM  Lilly's NDA for Selpercatinib Gets FDA's Priority Review Zacks
10:38AM  Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up Zacks
10:08AM  Eli Lilly beats profit estimates on strong demand for diabetes drug Trulicity Reuters
08:52AM  Eli Lilly Stock Is Climbing After a Glowing Earnings Report
08:33AM  Eli Lilly (LLY) Tops Q4 Earnings & Sales, Keeps 2020 View Zacks
08:00AM  Slapping Around Martin Shkreli Wont Cut Drug Prices Bloomberg
06:43AM  Dow futures drop over 200 points as coronavirus fears reboot MarketWatch
06:38AM  Eli Lilly's stock gains after earnings, revenue rise above expectations MarketWatch
06:25AM  Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition PR Newswire
06:15AM  Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis PR Newswire
04:38AM  Eli Lilly Posts Earnings Beat on Strong Demand for Trulicity and Taltz
03:38AM  Stocks - Facebook Slumps, Verizon Slips in Premarket, Tesla Surges
Jan-29-20 06:09PM  5 Top Non-Tech Earnings Charts Zacks
09:54AM  Alkermes' (ALKS) NDA for ALKS 3831 Accepted by FDA for Review Zacks
08:56AM  Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More Zacks
08:00AM  Eli Lilly Reports Earnings Tomorrow. Heres What to Expect.
07:30AM  CVS to offer diabetes drugs at no out-of-pocket costs for PBM members Reuters
06:45AM  Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application PR Newswire
Jan-28-20 02:36PM  Merck's Dificid Gets FDA Approval in Pediatric Indication Zacks
11:14AM  AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study Zacks
10:31AM  Lilly's Olumiant Meets Primary Goal in Dermatitis Study Zacks
10:20AM  Dr. Reddy's (RDY) Q3 Earnings and Revenues Increase Y/Y Zacks
07:12AM  The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics Benzinga
06:45AM  Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities PR Newswire
Jan-27-20 05:34PM  US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes PR Newswire
11:59AM  Eli Lilly Trading Near Top Of Buy Zone With Earnings On Tap Investor's Business Daily
11:30AM  Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year? Zacks
08:16AM  Lilly (LLY) to Report Q4 Earnings: What's in the Cards? Zacks
06:45AM  Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosporine PR Newswire
Jan-26-20 10:23AM  The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes Benzinga
Jan-24-20 05:50PM  Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know Zacks
02:16PM  Drug Stocks Slide as Never-Ending Political Worry Gathers Steam Bloomberg
11:08AM  After losing out on big prospect, O'Neill's Discovery Labs takes on cell-gene therapy manufacturing American City Business Journals
09:12AM  J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children Zacks
06:30AM  Anat Hakim to join Lilly as General Counsel PR Newswire
Jan-23-20 09:12AM  The Zacks Analyst Blog Highlights: Pfizer, Wells Fargo, SAP, and Eli Lilly Zacks
Jan-22-20 05:16PM  Steven Cohen's Point72 Piles Into Menlo Therapeutics
03:09PM  Durham is on a winning streak for new jobs, but will it continue? American City Business Journals
02:28PM  Health stocks reverse coronavirus gains as one analyst says the market is overreacting Yahoo Finance
12:41PM  Top Stock Analyst Reports for Pfizer, Wells Fargo & SAP Zacks
09:22AM  Glaxo's Multiple Myeloma Candidate Gets FDA's Priority Review Zacks
09:13AM  Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? Zacks
Jan-21-20 05:09PM  Pharma Company Buybacks: Do They Really Benefit Shareholders?
12:47PM  Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant PR Newswire
11:23AM  Eli Lilly and Company taps Durham for 450+ jobs, new facility American City Business Journals
Jan-18-20 02:40AM  Drugmakers slash prices to be eligible for China's bulk-buy program Reuters
Jan-17-20 02:47PM  9 Takeaways From The JPMorgan Healthcare Conference Benzinga
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; and positron emission tomography, as well as antibody for migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, thyroid, pancreatic, metastatic breast, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and other products to treat erectile dysfunction and benign prostatic hyperplasia. The company has collaboration with Incyte Corporation; Pfizer Inc; Dicerna Pharmaceuticals; AC Immune SA; and Avidity Biosciences, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.00970162Feb 18 02:57 PM
LILLY ENDOWMENT INC10% OwnerFeb 05Sale146.61200,00029,321,808113,520,304Feb 06 02:27 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,317045,623Feb 04 03:59 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0069,3500226,755Feb 04 03:54 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0013,0550113,266Feb 04 03:47 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.004,896025,166Feb 04 03:44 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale138.92205,00028,478,495113,720,304Jan 14 01:37 PM
LILLY ENDOWMENT INC10% OwnerJan 10Sale138.00210,00028,979,013113,925,304Jan 13 11:00 AM
LILLY ENDOWMENT INC10% OwnerJan 09Sale135.79220,00029,874,729114,135,304Jan 10 01:45 PM
LILLY ENDOWMENT INC10% OwnerJan 08Sale133.32172,65023,018,105114,355,304Jan 09 02:04 PM
LILLY ENDOWMENT INC10% OwnerJan 07Sale132.9032,6454,338,579114,527,954Jan 08 11:33 AM
LILLY ENDOWMENT INC10% OwnerDec 20Sale132.9019,7052,618,812114,560,599Dec 23 09:48 AM
LILLY ENDOWMENT INC10% OwnerDec 18Sale129.29220,00028,443,848114,580,304Dec 19 02:36 PM
LILLY ENDOWMENT INC10% OwnerDec 17Sale125.69215,00027,023,552114,800,304Dec 18 11:31 AM
LILLY ENDOWMENT INC10% OwnerDec 09Sale119.7010,9621,312,151115,015,304Dec 10 11:49 AM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 06Sale120.0025,0003,000,00033,414Dec 10 11:56 AM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 06Sale120.004,500540,00029,306Dec 09 04:37 PM
LILLY ENDOWMENT INC10% OwnerDec 06Sale120.15194,03823,313,498115,026,266Dec 09 09:51 AM
LILLY ENDOWMENT INC10% OwnerDec 04Sale118.52210,00024,890,040115,220,304Dec 05 01:31 PM
LILLY ENDOWMENT INC10% OwnerNov 27Sale117.5148,9535,752,257115,430,304Dec 02 01:40 PM
LILLY ENDOWMENT INC10% OwnerNov 26Sale117.8156,7296,683,470115,479,257Nov 27 10:40 AM
LILLY ENDOWMENT INC10% OwnerNov 25Sale117.60109,31812,855,797115,535,986Nov 26 11:19 AM
LILLY ENDOWMENT INC10% OwnerNov 22Sale116.25251,73629,263,596115,645,304Nov 25 04:29 PM
LILLY ENDOWMENT INC10% OwnerNov 21Sale115.14108,26412,465,506115,897,040Nov 22 10:56 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.06205,00023,586,776116,005,304Nov 20 10:17 AM
LILLY ENDOWMENT INC10% OwnerNov 18Sale114.0010,5981,208,172116,210,304Nov 19 12:00 PM
LILLY ENDOWMENT INC10% OwnerNov 12Sale114.007,981909,841116,220,902Nov 13 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 11Sale114.0710011,407116,228,883Nov 12 01:12 PM
LILLY ENDOWMENT INC10% OwnerNov 07Sale114.3740045,749116,228,983Nov 08 10:35 AM
LILLY ENDOWMENT INC10% OwnerNov 06Sale114.05173,91819,835,000116,229,383Nov 07 11:03 AM
LILLY ENDOWMENT INC10% OwnerNov 04Sale114.047,003798,608116,403,301Nov 05 01:18 PM
LILLY ENDOWMENT INC10% OwnerOct 31Sale114.00190,00021,659,646116,410,304Nov 01 10:37 AM
Ricks David APresident & CEOOct 25Buy108.384,615500,174157,405Oct 25 12:13 PM
White Anne E.SVP & Pres-Lilly OncologyOct 25Buy108.841,000108,84022,043Oct 28 03:11 PM
Smiley Joshua LSVP and CFOOct 25Buy107.5992999,95131,524Oct 28 03:06 PM
Skovronsky DanielSVP, CSO, and Pres. LRLOct 25Buy108.615,000543,05075,818Oct 28 03:00 PM
TAI JACKSON PDirectorOct 24Buy107.491,861200,03956,440Oct 25 12:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 20Sale117.004,500526,50033,806Sep 23 03:54 PM
LILLY ENDOWMENT INC10% OwnerSep 20Sale116.37210,00024,437,726116,600,304Sep 23 01:33 PM
Fry Stephen FSVP, HR & DiversitySep 05Sale115.009,4521,086,980100,211Sep 09 12:12 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 03Sale112.9119,5002,201,74538,306Sep 04 03:09 PM
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM